The interplay between TMEM43 and VDAC1 was also explored as a possible regulatory interaction, and TMEM43 appeared to activate VDAC1 through USP7 de-ubiquitination, representing a new predictive and treatment target for HCC. This evidence concerns the gene VDAC1 and hepatocellular carcinoma.